Viewing Study NCT02843035


Ignite Creation Date: 2025-12-24 @ 10:42 PM
Ignite Modification Date: 2026-02-25 @ 7:28 PM
Study NCT ID: NCT02843035
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-26
First Post: 2016-07-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module